In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are used in the collection, preparation, and examination of specimens taken from the human body. This includes Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers, Oncology and Reproductive Health Diagnostics. Colorectal Cancer Screening tests are carried to monitor bowel health of at-risk individuals, typically the elderly, in order to be able to detect and treat colorectal cancer in a timely manner. GlobalData uses proprietary data and analytics to provide a comprehensive report on the colorectal cancer screening tests devices market, including market shares of different players within New Zealand. Buy the latest report here.
In 2023, GlobalData’s Market Model methodology determined that the leading player in the colorectal cancer screening tests market in New Zealand was Eiken Chemical followed by Danaher, Thermo Fisher Scientific, Aerscher Diagnostics, Boditech Med, Sentinel CH., Alfresa Pharma, Resonac, Propper Manufacturing, McKesson, Hemosure, QuidelOrtho and Medline Industries.
Colorectal Cancer Screening Tests include Guaiac Fecal Occult Blood Test (gFOBT) Kits, Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits, Fecal DNA Test Kits, and Other Colorectal Cancer Screening Tests which cover blood-based assays used to screen for colorectal cancer by identifying changes in the methylation status of the Septin 9 gene.
The value of the colorectal cancer screening tests devices market within New Zealand was expected to be over $0.3m in 2023.
For the latest complete market share analysis of colorectal cancer screening tests device market in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.